Home › Trial NCT06806488
Study to Assess Clinical Characteristics and Outcome of Patients with Marginal Zone Lymphomas
- Trial IDNCT06806488
- StatusUnknown
- PhaseN/A
- Study typeObservational
- SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna
- Enrollment160
- Start date2025-05
- ConditionsMarginal Zone B Cell Lymphoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.